Magnetic resonance spectroscopy and its application in colorectal cancer diagnosis and screening: A narrative review

Grothey, 2004, Survival of patients with advanced colorectal cancer improves with the availability of fluorouracil-leucovorin, irinotecan, and oxaliplatin in the course of treatment, J Clin Oncol, 22, 1209, 10.1200/JCO.2004.11.037 Dolatkhah, 2015, Colorectal cancer in Iran: molecular epidemiology and screening strategies, J Cancer Epidemiol, 2015 Keyhani, 2003, Epidemiological evaluation of colorectal cancer, Acta Med Iran, 41, 156 Majumdar, 1999, How does colorectal cancer present? Symptoms, duration, and clues to location, Am J Gastroenterol, 94, 3039, 10.1111/j.1572-0241.1999.01454.x Wong, 2013, The knowledge of colorectal cancer symptoms and risk factors among 10,078 screening participants: are high risk individuals more knowledgeable?, PLoS One, 8, e60366, 10.1371/journal.pone.0060366 Lentjes, 2016 Winawer, 2003, Colorectal cancer screening and surveillance: clinical guidelines and rationale - update based on new evidence, Gastroenterology, 124, 544, 10.1053/gast.2003.50044 Gatto, 2003, Risk of perforation after colonoscopy and sigmoidoscopy: a population-based study, J Natl Cancer Inst, 95, 230, 10.1093/jnci/95.3.230 Rabeneck, 2008, Bleeding and perforation after outpatient colonoscopy and their risk factors in usual clinical practice, Gastroenterology, 135, 1899, 10.1053/j.gastro.2008.08.058 Lüning, 2007, Colonoscopic perforations: a review of 30,366 patients, Surg Endosc, 21, 994, 10.1007/s00464-007-9251-7 Arora, 2009, Risk of perforation from a colonoscopy in adults: a large population-based study, Gastrointest Endosc, 69, 654, 10.1016/j.gie.2008.09.008 Calonge, 2008, Screening for colorectal cancer, Ann Intern Med, 149, 627, 10.7326/0003-4819-149-9-200811040-00243 Cokkinides, 2003, Correlates of underutilization of colorectal cancer screening among US adults, age 50 years and older, Prev Med, 36, 85, 10.1006/pmed.2002.1127 Allison, 2007, Screening for colorectal neoplasms with new fecal occult blood tests: update on performance characteristics, J Natl Cancer Inst, 99, 1462, 10.1093/jnci/djm150 Imperiale, 2004, Fecal DNA versus fecal occult blood for colorectal-cancer screening in an average-risk population, N Engl J Med, 351, 2704, 10.1056/NEJMoa033403 Force, 2002, Screening for colorectal cancer: recommendation and rationale, Ann Intern Med, 137, 129, 10.7326/0003-4819-137-2-200207160-00014 Sonnenberg, 2000, Cost-effectiveness of colonoscopy in screening for colorectal cancer, Ann Intern Med, 133, 573, 10.7326/0003-4819-133-8-200010170-00007 Levin, 2003, Emerging technologies in screening for colorectal cancer: CT colonography, immunochemical fecal occult blood tests, and stool screening using molecular markers, CA A Cancer J Clin, 53, 44, 10.3322/canjclin.53.1.44 Tonus, 2006, Colorectal cancer screening by non-invasive metabolic biomarker fecal tumor M2-PK, World J Gastroenterol, 12, 7007, 10.3748/wjg.v12.i43.7007 Lan, 2017, Stool DNA testing for colorectal cancer screening in an urban medical center, Gastroenterology, 152, S551, 10.1016/S0016-5085(17)32001-2 Marshall, 2017, Beyond the paradigm: combining mass spectrometry and nuclear magnetic resonance for metabolomics, Prog Nucl Magn Reson Spectrosc, 100, 1, 10.1016/j.pnmrs.2017.01.001 Forsgren, 2017 Meyerand, 1999, Classification of biopsy-confirmed brain tumors using single-voxel MR spectroscopy, Am J Neuroradiol, 20, 117 Faghihi, 2017, Magnetic resonance spectroscopy and its clinical applications: a review, J Med Imag Radiat Sci, 48, 233, 10.1016/j.jmir.2017.06.004 Kong, 2018, Research progression of blood and fecal metabolites in colorectal cancer, IJS Oncol, 3, e51, 10.1097/IJ9.0000000000000051 Nguyen, 2014, The potential role of magnetic resonance spectroscopy in image-guided radiotherapy, Front Oncol, 4, 91, 10.3389/fonc.2014.00091 Drost, 2002, Proton magnetic resonance spectroscopy in the brain: report of AAPM MR Task Group #9, Med Phys, 29, 2178, 10.1118/1.1501822 Saeedi-Moghadam, 2018, Fast Padé Transform for increasing the signal to noise ratio of spectra provided by STEAM pulse sequence, Technol Health Care, 1 Bertholdo, 2013, Brain proton magnetic resonance spectroscopy: introduction and overview, Neuroimaging Clin N Am, 23, 359, 10.1016/j.nic.2012.10.002 Lean, 1993, Assessment of human colorectal biopsies by 1H MRS: correlation with histopathology, Magn Reson Med, 30, 525, 10.1002/mrm.1910300502 Zeinali-Rafsanjani, 2018, MRS shimming: an important point which should not be ignored, J Biomed Phys Eng, 8, 261 Tzika, 2002, Biochemical characterization of pediatric brain tumors by using in vivo and ex vivo magnetic resonance spectroscopy, J Neurosurg, 96, 1023, 10.3171/jns.2002.96.6.1023 Jung, 1999, Biochemical markers of cognition: a proton MR spectroscopy study of normal human brain, Neuroreport, 10, 3327, 10.1097/00001756-199911080-00014 Kantarci, 2014, 1H magnetic resonance spectroscopy in dementia, Br J Radiol, 80, S146, 10.1259/bjr/60346217 Tao, 2017, A comparison of neurometabolites between remitted bipolar disorder and depressed bipolar disorder: a proton magnetic resonance spectroscopy study, J Affect Disord, 211, 153, 10.1016/j.jad.2017.01.009 Szczepaniak, 2005, Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population, Am J Physiol Endocrinol Metab, 288, E462, 10.1152/ajpendo.00064.2004 Zeinali-Rafsanjani, 2019, A method for cranial target delineation in radiotherapy treatment planning aided by single-voxel magnetic resonance spectroscopy: evaluation using a custom-designed gel-based phantom and simulations, Br J Radiol, 92, 20190216, 10.1259/bjr.20190216 Bottomley, 1994, MR spectroscopy of the human heart: the status and the challenges, Radiology, 191, 593, 10.1148/radiology.191.3.8184033 Jiménez-Xarrié, 2015, In vivo and ex vivo magnetic resonance spectroscopy of the infarct and the subventricular zone in experimental stroke, J Cerebr Blood Flow Metabol, 35, 828, 10.1038/jcbfm.2014.257 Martínez-Bisbal, 2004, 1H and 13C HR-MAS spectroscopy of intact biopsy samples ex vivo and in vivo1H MRS study of human high grade gliomas, NMR Biomed, 17, 191, 10.1002/nbm.888 Rutter, 1995, Classification of brain tumors by ex vivo 1H NMR spectroscopy, J Neurochem, 64, 1655, 10.1046/j.1471-4159.1995.64041655.x Heude, 2017, Nuclear magnetic resonance strategies for metabolic analysis, 45 Beckonert, 2010, High-resolution magic-angle-spinning NMR spectroscopy for metabolic profiling of intact tissues, Nat Protoc, 5, 1019, 10.1038/nprot.2010.45 Tugnoli, 2006, Ex vivo HR-MAS MRS of human meningiomas: a comparison with in vivo 1H MR spectra, Int J Mol Med, 18, 859 Wilson, 2009, A quantitative comparison of metabolite signals as detected by in vivo MRS with ex vivo 1H HR-MAS for childhood brain tumours, NMR Biomed, 22, 213, 10.1002/nbm.1306 Sitter, 2009, High-resolution magic angle spinning (HR MAS) MR spectroscopy in metabolic characterization of human cancer, Prog Nucl Magn Reson Spectrosc, 54, 239, 10.1016/j.pnmrs.2008.10.001 Sitter, 2010, Quantification of metabolites in breast cancer patients with different clinical prognosis using HR MAS MR spectroscopy, NMR Biomed, 23, 424, 10.1002/nbm.1478 Jiménez, 2013, 1H HR-MAS NMR spectroscopy of tumor-induced local metabolic “field-effects” enables colorectal cancer staging and prognostication, J Proteome Res, 12, 959, 10.1021/pr3010106 Chan, 2008, Metabolic profiling of human colorectal cancer using high-resolution magic angle spinning nuclear magnetic resonance (HR-MAS NMR) spectroscopy and gas chromatography mass spectrometry (GC/MS), J Proteome Res, 8, 352, 10.1021/pr8006232 Kekelidze, 2013, Colorectal cancer: current imaging methods and future perspectives for the diagnosis, staging and therapeutic response evaluation, World J Gastroenterol, 19, 8502, 10.3748/wjg.v19.i46.8502 Zamani, 2014, A metabolic study on colon cancer using 1H nuclear magnetic resonance spectroscopy, Biochem Res Int, 2014, 348712, 10.1155/2014/348712 Verma, 2015, Metabolomic approaches in cancer epidemiology, Diseases, 3, 167, 10.3390/diseases3030167 Ramadan, 2006, Metabolic profiling using principal component analysis, discriminant partial least squares, and genetic algorithms, Talanta, 68, 1683, 10.1016/j.talanta.2005.08.042 Eriksson, 2006, Megavariate analysis of environmental QSAR data. Part I–A basic framework founded on principal component analysis (PCA), partial least squares (PLS), and statistical molecular design (SMD), Mol Divers, 10, 169, 10.1007/s11030-006-9024-6 Chevallier, 2006, Application of PLS-DA in multivariate image analysis, J Chemometr, 20, 221, 10.1002/cem.994 Wishart, 2009, HMDB: a knowledgebase for the human metabolome, Nucleic Acids Res, 37, D603, 10.1093/nar/gkn810 Brown, 2016, Metabolomics and metabolic pathway networks from human colorectal cancers, adjacent mucosa, and stool, Canc Metabol, 4, 11, 10.1186/s40170-016-0151-y Bezabeh, 2009, Detecting colorectal cancer by 1H magnetic resonance spectroscopy of fecal extracts, NMR Biomed, 22, 593, 10.1002/nbm.1372 Bjerrum, 2015, Metabonomics of human fecal extracts characterize ulcerative colitis, Crohn's disease and healthy individuals, Metabolomics, 11, 122, 10.1007/s11306-014-0677-3 Ndagijimana, 2009, Effect of a synbiotic food consumption on human gut metabolic profiles evaluated by 1 H Nuclear Magnetic Resonance spectroscopy, Int J Food Microbiol, 134, 147, 10.1016/j.ijfoodmicro.2009.04.016 Hahn, 1997, The classification of benign and malignant human prostate tissue by multivariate analysis of 1H magnetic resonance spectra, Canc Res, 57, 3398 Le Gall, 2018, Metabolite quantification of faecal extracts from colorectal cancer patients and healthy controls, Oncotarget, 9, 33278, 10.18632/oncotarget.26022 Lin, 2016, NMR-based fecal metabolomics fingerprinting as predictors of earlier diagnosis in patients with colorectal cancer, Oncotarget, 7, 29454, 10.18632/oncotarget.8762 Seierstad, 2008, Principal component analysis for the comparison of metabolic profiles from human rectal cancer biopsies and colorectal xenografts using high-resolution magic angle spinning 1 H magnetic resonance spectroscopy, Mol Cancer, 7, 33, 10.1186/1476-4598-7-33 Merchant, 1991, Phospholipid profiles of human colon cancer using 31 P magnetic resonance spectroscopy, Int J Colorectal Dis, 6, 121, 10.1007/BF00300208 Merchant, 1991, Phospholipid profiles of human colon cancer, Thomas Edward Merchant, 6, 89 Mansilla, 2009, Lysophosphatidylcholine acyltransferase 1 (LPCAT1) overexpression in human colorectal cancer, J Mol Med, 87, 85, 10.1007/s00109-008-0409-0 Howe, 2003, Metabolic profiles of human brain tumors using quantitative in vivo 1H magnetic resonance spectroscopy, Magn Reson Med, 49, 223, 10.1002/mrm.10367 Tedeschi, 1997, Increased choline signal coinciding with malignant degeneration of cerebral gliomas: a serial proton magnetic resonance spectroscopy imaging study, J Neurosurg, 87, 516, 10.3171/jns.1997.87.4.0516 Laprie, 2008, Proton magnetic resonance spectroscopic imaging in newly diagnosed glioblastoma: predictive value for the site of postradiotherapy relapse in a prospective longitudinal study, Int J Radiat Oncol Biol Phys, 70, 773, 10.1016/j.ijrobp.2007.10.039 Usenius, 1994, Choline-containing compounds in human astrocytomas studied by 1H NMR spectroscopy in vivo and in vitro, J Neurochem, 63, 1538, 10.1046/j.1471-4159.1994.63041538.x Saeedi-Moghadam, 2019, Assessment the influencing factors on MRS signal obtained from high magnetic field strength (1.5 T) MRI scanners during the application of homemade metabolite phantom, J Magnet, 24, 90, 10.4283/JMAG.2019.24.1.090 Halligan, 2013, Computed tomographic colonography versus barium enema for diagnosis of colorectal cancer or large polyps in symptomatic patients (SIGGAR): a multicentre randomised trial, Lancet, 381, 1185, 10.1016/S0140-6736(12)62124-2 Atkin, 2013, Computed tomographic colonography versus colonoscopy for investigation of patients with symptoms suggestive of colorectal cancer (SIGGAR): a multicentre randomised trial, Lancet, 381, 1194, 10.1016/S0140-6736(12)62186-2 Bressler, 2004, Colonoscopic miss rates for right-sided colon cancer: a population-based analysis, Gastroenterology, 127, 452, 10.1053/j.gastro.2004.05.032 Bressler, 2007, Rates of new or missed colorectal cancers after colonoscopy and their risk factors: a population-based analysis, Gastroenterology, 132, 96, 10.1053/j.gastro.2006.10.027